GI-4000 With Adoptive Transfer in Pancreatic Cancer
Condition(s):Pancreatic CancerLast Updated:August 17, 2016Withdrawn
Hide Studies Not Open or Pending
Condition(s):Pancreatic CancerLast Updated:August 17, 2016Withdrawn
Condition(s):Chronic Lymphocytic LeukemiaLast Updated:July 5, 2018Completed
Condition(s):Cancer; Relapsed/Refractory Large B-cell Lymphoma (LBCL)Last Updated:March 21, 2024Recruiting
Condition(s):Acquired Immunodeficiency Syndrome; HIV InfectionLast Updated:March 4, 2008Completed
Condition(s):Solid Tumor, Adult; Refractory Cancer; Recurrent Cancer; CancerLast Updated:February 26, 2024Completed
Condition(s):Solid Tumor; Cancer; Recurrent Solid Tumors; Refractory Solid TumorsLast Updated:January 22, 2024Completed
Condition(s):Relapsed or Refractory B-Cell Non-Hodgkin LymphomaLast Updated:November 6, 2014Unknown status
Condition(s):B-NHL; B-Non Hodgkin Lymphoma; Acute Lymphocytic Leukemia; Acute Lymphoblastic Leukemia; B-precursor ALL; B-All; Lymphoma, Non-Hodgkin; Leukemia, Lymphocytic, B Cell; B-Cell Lymphoma; B-Cell Leukemia; Acute Lymphoid LeukemiaLast Updated:January 26, 2024Recruiting
Condition(s):Relapsed or Refractory CD19+ B-cell Lymphoma; Relapsed or Refractory Chronic Lymphocytic Leukemia; Relapsed or Refractory Small Lymphocytic LymphomaLast Updated:March 18, 2024Recruiting
Condition(s):Relapsed/Refractory Aggressive B-Cell MalignanciesLast Updated:November 30, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.